World's Best Scientists 2026 revealed!
VIEW LIST
Andreas Schneeweiss

D-Index & Metrics

Medicine

D-Index
106
Citations
61466
World Ranking
6381
National Ranking
362

Andreas Schneeweiss publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Andreas Schneeweiss sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,122 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Andreas Schneeweiss D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Andreas Schneeweiss sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Andreas Schneeweiss is affiliated with the German Cancer Research Center in Germany. Their research primarily focuses on oncology and cancer-related studies, contributing extensively to the fields of Medicine as well as Biochemistry, Genetics, and Molecular Biology. The main subfields in which they are active include Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics, and Radiology, Nuclear Medicine, and Imaging.

Their work centers on a range of cancer-related topics, notably:

  • Advanced Breast Cancer Therapies
  • Breast Cancer Treatment Studies
  • HER2/EGFR in Cancer Research
  • Cancer Treatment and Pharmacology
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Cancer Cells and Metastasis

Schneeweiss has contributed to numerous publications across reputable journals. Frequent venues for their research publications include:

  • Annals of Oncology (50 publications)
  • Cancer Research (44 publications)
  • Geburtshilfe und Frauenheilkunde (42 publications)
  • Senologie - Zeitschrift für Mammadiagnostik und -therapie (39 publications)
  • Journal of Clinical Oncology (19 publications)

Selected recent papers authored or co-authored by Andreas Schneeweiss include:

  • "Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study," 2020, The Lancet Oncology
  • "Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer," 2021, Annals of Oncology
  • "Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials," 2021, The Lancet Oncology
  • "First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis," 2021, Annals of Oncology
  • "Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study," 2021, JNCI Journal of the National Cancer Institute

Frequent collaborators include:

  • Peter A. Fasching (179 joint publications)
  • Michael Untch (125 joint publications)
  • Volkmar Müller (121 joint publications)
  • Tanja Fehm (120 joint publications)
  • Wolfgang Janni (109 joint publications)

Best Publications

  • Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

    Peter Schmid;Stephen Y Chui;Leisha A Emens

  • Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer

    Sandra M. Swain;José Baselga;Sung-Bae Kim;Jungsil Ro

  • Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

    Gunter Von Minckwitz;Chiun Sheng Huang;Max S. Mano;Sibylle Loibl

  • Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy

    Carsten Denkert;Gunter von Minckwitz;Silvia Darb-Esfahani;Bianca Lederer

  • Association analysis identifies 65 new breast cancer risk loci

    Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley

  • Large-scale genotyping identifies 41 new loci associated with breast cancer risk

    Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini

  • Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

    A. Schneeweiss;S. Chia;T. Hickish;V. Harvey

  • Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

    David W. Miles;Arlene Chan;Luc Y. Dirix;Javier Cortés

  • Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study

    Sandra M Swain;Sung-Bae Kim;Javier Cortés;Jungsil Ro

  • Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

    Irène Baccelli;Andreas Schneeweiss;Sabine Riethdorf;Albrecht Stenzinger

  • Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial

    Peter Schmid;Hope S Rugo;Sylvia Adams;Andreas Schneeweiss

  • Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

    Gunter von Minckwitz;Andreas Schneeweiss;Sibylle Loibl;Christoph Salat

  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

    Nasim Mavaddat;Kyriaki Michailidou;Kyriaki Michailidou;Joe Dennis;Michael Lush

  • Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women

    Leila Dorling;Sara Carvalho;Jamie Allen

  • Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

    Sandra M Swain;Sandra M Swain;David Miles;Sung-Bae Kim;Young-Hyuck Im

  • Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

    Brigitte Rack;Christian Schindlbeck;Julia Jückstock;Ulrich Andergassen

  • Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

    Miguel Martin;Frankie A Holmes;Bent Ejlertsen;Suzette Delaloge

  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

    Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley

  • Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

    Nasim Mavaddat;Paul D.P. Pharoah;Kyriaki Michailidou;Jonathan Tyrer

  • MicroRNA related polymorphisms and breast cancer risk

    Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne

Frequent Co-Authors

Michael Untch
Michael Untch Helios Klinikum Berlin-Buch
Barbara Burwinkel
Barbara Burwinkel Heidelberg University
Peter A. Fasching
Peter A. Fasching University of Erlangen-Nuremberg
Matthias W. Beckmann
Matthias W. Beckmann University of Erlangen-Nuremberg
Christian Jackisch
Christian Jackisch Breast Cancer Research Foundation
Sibylle Loibl
Sibylle Loibl Goethe University Frankfurt
Jens Huober
Jens Huober Kantonsspital St. Gallen
Tanja Fehm
Tanja Fehm Heinrich Heine University Düsseldorf
Carsten Denkert
Carsten Denkert Philipp University of Marburg
Volkmar Müller
Volkmar Müller Universität Hamburg

External Links

Personal website of Andreas Schneeweiss

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine but want flexible study options, online nursing degrees offer a practical path. Many institutions now offer programs that allow you to earn highly respected qualifications from home. For those looking to advance their careers quickly and affordably, the cheapest nurse practitioner programs can lead to advanced clinical roles while minimizing student debt.

If you’re just starting on your journey, look into the cheapest online bsn programs for foundational nursing education. Registered nurses who already have a diploma or ADN can further their education through the cheapest rn to bsn programs, opening up more job opportunities and higher earning potential.

For those interested in leadership, research, or academic roles, pursuing a phd nursing education online can help you reach the highest levels of the nursing profession. With these online pathways, flexible and affordable options are available for every stage of your healthcare career.

Best Scientists Citing Andreas Schneeweiss

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 259

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 189

Roger L. Milne

Roger L. Milne

Cancer Council Victoria

Publications: 188

Paul D.P. Pharoah

Paul D.P. Pharoah

University of Cambridge

Publications: 168

Douglas F. Easton

Douglas F. Easton

University of Cambridge

Publications: 163

Melissa C. Southey

Melissa C. Southey

Monash University

Publications: 141

Hiltrud Brauch

Hiltrud Brauch

German Cancer Research Center

Publications: 137

Matthias W. Beckmann

Matthias W. Beckmann

University of Erlangen-Nuremberg

Publications: 136

Peter A. Fasching

Peter A. Fasching

University of Erlangen-Nuremberg

Publications: 125

Wei Zheng

Wei Zheng

Vanderbilt University Medical Center

Publications: 124

Per Hall

Per Hall

Karolinska Institute

Publications: 120

John L. Hopper

John L. Hopper

University of Melbourne

Publications: 118

Alison M. Dunning

Alison M. Dunning

University of Cambridge

Publications: 115

Georgia Chenevix-Trench

Georgia Chenevix-Trench

QIMR Berghofer Medical Research Institute

Publications: 110

Irene L. Andrulis

Irene L. Andrulis

University of Toronto

Publications: 110

Christopher A. Haiman

Christopher A. Haiman

University of Southern California

Publications: 110

Trending Scientists

Christopher Lee

Christopher Lee

University of California, Los Angeles

Carol Shennan

Carol Shennan

University of California, Santa Cruz

Luigi Danese

Luigi Danese

International School for Advanced Studies

Sien Li

Sien Li

China Agricultural University

Asaph Aharoni

Asaph Aharoni

Weizmann Institute of Science

Adriana Ferreira

Adriana Ferreira

Northwestern University

Grant James Anhalt

Grant James Anhalt

Johns Hopkins University

Rolf Lidskog

Rolf Lidskog

Örebro University

Brian R. Gaines

Brian R. Gaines

University of Victoria

Sasha Omanovic

Sasha Omanovic

McGill University

Richard B. Silverman

Richard B. Silverman

Northwestern University

Huizhen Liu

Huizhen Liu

Chinese Academy of Sciences

Peter J Trainer

Peter J Trainer

University of Manchester

Matthew J. Silva

Matthew J. Silva

Washington University in St. Louis

Barry R. Davis

Barry R. Davis

The University of Texas Health Science Center at Houston

Faryar Jabbari

Faryar Jabbari

University of California, Irvine

Related Medicine Rankings & Guides

2026 Fastest Online RN to MSN (No ADN Required) Bridge Programs

2026 Fastest Online RN to MSN (No ADN Required) Bridge Programs
2026 Best Paramedic-to-RN Bridge Programs

2026 Best Paramedic-to-RN Bridge Programs
2026 Fastest Online Medical Billing and Coding Certificate Programs

2026 Fastest Online Medical Billing and Coding Certificate Programs
2026 Best Nursing Schools in Utah – Accredited ADN, BSN & MSN Programs

2026 Best Nursing Schools in Utah – Accredited ADN, BSN & MSN Programs
2026 Easiest Nurse Practitioner Degree Programs

2026 Easiest Nurse Practitioner Degree Programs
2026 Easiest Nurse Practitioner Specialty Programs to Get Into

2026 Easiest Nurse Practitioner Specialty Programs to Get Into
2026 Best Online DNP Programs Without Clinicals

2026 Best Online DNP Programs Without Clinicals
2026 Easiest DNP Programs

2026 Easiest DNP Programs
August 2026 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs

August 2026 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs
2026 Best Online MSN in Health/Nursing Informatics Programs

2026 Best Online MSN in Health/Nursing Informatics Programs
2026 Fastest Online Pharmacy Technician Certificate Programs

2026 Fastest Online Pharmacy Technician Certificate Programs
2026 How Much Do Medical Assistant Programs & Certifications Cost?

2026 How Much Do Medical Assistant Programs & Certifications Cost?
2026 Easiest Radiology Programs to Get Into

2026 Easiest Radiology Programs to Get Into
2026 Best Shortest Online MSN Programs

2026 Best Shortest Online MSN Programs
2026 Fastest Online MSN in Forensic Nursing Programs

2026 Fastest Online MSN in Forensic Nursing Programs
2026 Best Online DNP Programs

2026 Best Online DNP Programs
2026 Best Online Master’s in Clinical Research Programs

2026 Best Online Master’s in Clinical Research Programs
2026 Most Affordable Online Medical Assistant Programs

2026 Most Affordable Online Medical Assistant Programs
2026 Best Online CAHME-Accredited MHA Programs

2026 Best Online CAHME-Accredited MHA Programs
2026 Healthcare Degree Programs You Can Earn in 2 Years or Less

2026 Healthcare Degree Programs You Can Earn in 2 Years or Less
2026 Fastest Online MSN in Psychiatric Mental Health NP Programs

2026 Fastest Online MSN in Psychiatric Mental Health NP Programs

Recently Published Articles

2026 How Fast Can You Get a Mechanical Engineering Degree Online?

2026 How Fast Can You Get a Mechanical Engineering Degree Online?
2026 How to Become a Nurse Midwife in Massachusetts - Midwife Schooling Requirements

2026 How to Become a Nurse Midwife in Massachusetts - Midwife Schooling Requirements
2026 Fastest Online Public Policy Bachelor's Degree Programs You Can Finish in 3 Years or Less

2026 Fastest Online Public Policy Bachelor's Degree Programs You Can Finish in 3 Years or Less
2026 Best Bookkeeping Certificate Programs

2026 Best Bookkeeping Certificate Programs
2026 Online Ultrasound Technology Degree Programs for Veterans: GI Bill Benefits, Costs & Top Considerations

2026 Online Ultrasound Technology Degree Programs for Veterans: GI Bill Benefits, Costs & Top Considerations
2026 One-Year Online Speech Pathology Master's Degree Programs: Accelerated Options, Costs & Outcomes

2026 One-Year Online Speech Pathology Master's Degree Programs: Accelerated Options, Costs & Outcomes
2026 Best LPN Programs in Utah – Accredited Online LPN Programs

2026 Best LPN Programs in Utah – Accredited Online LPN Programs
2026 Online Public Health Degrees With Maternal and Child Health Concentrations

2026 Online Public Health Degrees With Maternal and Child Health Concentrations
2026 History Degree Salary by Experience Level: Entry-Level, Mid-Career, and Senior Roles

2026 History Degree Salary by Experience Level: Entry-Level, Mid-Career, and Senior Roles
2026 Best Online DNP Programs Without Clinicals

2026 Best Online DNP Programs Without Clinicals
2026 Cheapest Online Adult Gerontology Primary Care Nurse Practitioner Master's Degrees That Pay Well: Tuition, Duration, and Earnings

2026 Cheapest Online Adult Gerontology Primary Care Nurse Practitioner Master's Degrees That Pay Well: Tuition, Duration, and Earnings
2026 Can You Get Into an Engineering Program with a Low GPA? Admission Chances & Workarounds

2026 Can You Get Into an Engineering Program with a Low GPA? Admission Chances & Workarounds
2026 How Fast Can You Get an Architecture Degree Online?

2026 How Fast Can You Get an Architecture Degree Online?
2026 How to Become a Caregiver: Certification Requirements in Oregon

2026 How to Become a Caregiver: Certification Requirements in Oregon
2026 Become a Medical Assistant in 6 Weeks – Best Accelerated Programs

2026 Become a Medical Assistant in 6 Weeks – Best Accelerated Programs
2026 Entry-Level Jobs With a Data Science Master's Degree

2026 Entry-Level Jobs With a Data Science Master's Degree
2026 Easy Certifications That Pay Well

2026 Easy Certifications That Pay Well
2026 How to Become a Licensed Mental Health Counselor (LMHC)

2026 How to Become a Licensed Mental Health Counselor (LMHC)
2026 Highest-Paying Jobs with a Nutrition Master's Degree

2026 Highest-Paying Jobs with a Nutrition Master's Degree
2026 Massachusetts MFT Licensing, Certifications, Careers and Requirements

2026 Massachusetts MFT Licensing, Certifications, Careers and Requirements
2026 Are There Any One-Year Online Neuroscience Degree Programs Worth Considering?

2026 Are There Any One-Year Online Neuroscience Degree Programs Worth Considering?